Chronic Thalidomide and Chemoembolization for Hepatocellular Carcinoma

BACKGROUND. Transcatheter arterial chemoembolization (TACE) has been used to curtail tumor vasculature and delay tumor progression in hepatocellular carcinoma (HCC). We conducted a phase I trial to evaluate the efficacy and toxicity of thalidomide when combined with TACE in patients with advanced HC...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncologist
Main Authors: Wu, Jennifer, Ng, Jennifer, Christos, Paul J., Goldenberg, Alec S., Sparano, Joseph, Sung, Max W., Hochster, Howard S., Muggia, Franco M.
Formato: Artigo
Idioma:Inglês
Publicado: AlphaMed Press 2014
Assuntos:
Clinical Trial Results
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4257750/
https://ncbi.nlm.nih.gov/pubmed/25361625
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0283
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares